Showing 2,101 - 2,120 results of 102,493 for search '(( 30 point decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 2101

    A Point Mutation in a lincRNA Upstream of <i>GDNF</i> Is Associated to a Canine Insensitivity to Pain: A Spontaneous Model for Human Sensory Neuropathies by Jocelyn Plassais (564630)

    Published 2016
    “…Clinical signs appear in young puppies and consist of acral analgesia, with or without sudden intense licking, biting and severe self-mutilation of the feet, whereas proprioception, motor abilities and spinal reflexes remain intact. Through a Genome Wide Association Study (GWAS) with 24 affected and 30 unaffected sporting dogs using the Canine HD 170K SNP array (Illumina), we identified a 1.8 Mb homozygous locus on canine chromosome 4 (adj. p-val = 2.5x10<sup>-6</sup>). …”
  2. 2102
  3. 2103
  4. 2104
  5. 2105
  6. 2106
  7. 2107
  8. 2108
  9. 2109

    Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  10. 2110

    Protocol measures. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  11. 2111

    Cry variables. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  12. 2112

    Critical Membrane Concentration and Mass-Balance Model to Identify Baseline Cytotoxicity of Hydrophobic and Ionizable Organic Chemicals in Mammalian Cell Lines by Jungeun Lee (142511)

    Published 2021
    “…However, their applicability is limited to hydrophilic neutral compounds. To develop a prediction model that includes more hydrophobic and charged organic chemicals, a mass balance model was applied for mammalian cells (AREc32, AhR-CALUX, PPARγ-BLA, and SH-SY5Y) considering different bioassay conditions. …”
  13. 2113
  14. 2114
  15. 2115
  16. 2116
  17. 2117
  18. 2118
  19. 2119
  20. 2120

    S1 Data - by Saori Miyagishima (14593506)

    Published 2023
    Subjects: